Keith Jerome shows us how gene editing can lead to the elimination of the vast majority of latent herpes simplex virus from reservoirs sites in the body--which can teach us how to do the same for HIV--at the 5th Conference on Cell and Gene Therapy for HIV Cure 2019.
Born out of the desire to bring much needed attention to HIV cell and gene therapies, this conference aims to advance the pursuit of an HIV cure by bringing together an international roster of esteemed scientists to share and review the latest cell and gene therapy approaches targeting HIV.
Hosted in Seattle, Washington on August 22-23, 2019 by the defeatHIV Martin Delany Collaboratory, in collaboration with the Fred Hutchinson Cancer Research Center, the University of Washington/Fred Hutch Center for AIDS Research (UW/Fred Hutch CFAR) and the UW Virology Division.
MORE ABOUT defeatHIV:
Founded in 2011 and led by Drs. Keith Jerome and Hans-Peter Kiem at the Fred Hutchinson Cancer Research Center, the defeatHIV Martin Delaney Collaboratory is a consortium of scientific investigators and clinicians from both public and private research organizations who are committed to finding a cure for HIV.
We are supported through a program sponsored by the National Institutes of Health and the National Institute of Allergy and Infectious Disease in honor of AIDS activist Martin Delaney.
The Martin Delaney Collaboratory program focuses on providing support for HIV research strategies that are curative and fosters partnerships between public and private research organizations.
